University of Southampton
Anthracenyl amino acid analogues as topoisomerase I inhibitors
Abstract
dc:description.abstract<p>Topoisomerases are enzymes which alter the topological state of DNA. Mammalian type I and II topoisomerases (topo I and II) alter the linking number (L) of DNA by a factor of 1 and 2 respectively, thus reducing levels of supercoiling in mammalian DNA according to the equation L=T+W where T is the twisting number and W the writhing number. These enzymes are therefore essential for DNA metabolism and cell replication. A number of clinical useful anticancer drugs including camptothecin, doxorubicin and etoposide have been shown to inhibit the catalytic cycle of the topoisomerases, suggesting a mechanism of cell kill at least partially involving topo inhibition.</p><p>A method for the synthesis of anthracenyl amino acid and peptide conjugates has been established. This class of compound has been reported to possess inhibitory activity against topo I. A range of novel compounds were therefore synthesised and evaluated as topoisomerase I inhibitors and structure activity relationships obtained. The amino acid conjugate 1-[Tyr]-4-hydroxy-anthraquinone was shown to be the most active compound in the series with regards to topo I inhibition. When compared to 0.1 μM camptothecin it was shown to possess similar activity to the known inhibitor at the higher concentration of 125 μM.</p>
Degree
thesis:*- Name dc:type.qualificationname
- Ph.D.
- Level dc:type.qualificationlevel
- doctoral
- Grantor dc:publisher.institution
- University of Southampton
- Year dc:date.issued
- 2000
Author and committee
dc:creator, dc:contributor.*- Author dc:creator
-
- Giles, Gregory
Rights
- Language dc:language
- English, eng